159 related articles for article (PubMed ID: 34620788)
1. COVID-19 outcomes in people with cystic fibrosis.
Burgel PR; Goss C
Curr Opin Pulm Med; 2021 Nov; 27(6):538-543. PubMed ID: 34620788
[TBL] [Abstract][Full Text] [Related]
2. TGF-β1 Inhibition of ACE2 Mediated by miRNA Uncovers Novel Mechanism of SARS-CoV-2 Pathogenesis.
Hejenkowska ED; Mitash N; Donovan JE; Chandra A; Bertrand C; De Santi C; Greene CM; Mu F; Swiatecka-Urban A
J Innate Immun; 2023; 15(1):629-646. PubMed ID: 37579743
[TBL] [Abstract][Full Text] [Related]
3. Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020.
Naehrlich L; Orenti A; Dunlevy F; Kasmi I; Harutyunyan S; Pfleger A; Keegan S; Daneau G; Petrova G; Tješić-Drinković D; Yiallouros P; Bilkova A; Olesen HV; Burgel PR; Parulava T; Diamantea F; Párniczky A; McKone EF; Mei-Zahav M; Salvatore M; Colombo C; Aleksejeva E; Malakauskas K; Schlesser M; Fustik S; Turcu O; Zomer-van Ommen D; Wathne AS; Woźniacki Ł; Pereira L; Pop L; Kashirskaya N; Rodić M; Kayserova H; Krivecs U; Mondejar-Lopez P; de Monestrol I; Dogru D; Makukh H; Cosgriff R; van Koningsbruggen-Rietschel S; Jung A;
J Cyst Fibros; 2021 Jul; 20(4):566-577. PubMed ID: 34016559
[TBL] [Abstract][Full Text] [Related]
4. Cumulative Incidence and Risk Factors for Severe Coronavirus Disease 2019 in French People With Cystic Fibrosis.
Corvol H; de Miranda S; Dehillotte C; Lemonnier L; Chiron R; Danner-Boucher I; Hamidfar R; Houdouin V; Macey J; Marguet C; Murris-Espin M; Reynaud Q; Reix P; Reynaud Gaubert M; Kemgang A; Burgel PR;
Clin Infect Dis; 2022 Dec; 75(12):2135-2144. PubMed ID: 35475917
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis.
Hergenroeder GE; Faino AV; Cogen JD; Genatossio A; McNamara S; Pascual M; Hernandez RE
Pediatr Pulmonol; 2023 Sep; 58(9):2478-2486. PubMed ID: 37314149
[TBL] [Abstract][Full Text] [Related]
6. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey.
Mondejar-Lopez P; Quintana-Gallego E; Giron-Moreno RM; Cortell-Aznar I; Ruiz de Valbuena-Maiz M; Diab-Caceres L; Prados-Sanchez C; Alvarez-Fernandez A; Garcia-Marcos PW; Peñalver-Mellado C; Pastor-Vivero MD; Olveira C; Lopez-Neyra A; Castillo-Corullon S; Palma-Milla S; Perez-Ruiz E; Sole-Jover A; Barrio MI; Sanchez-Solis M; Asensio de la Cruz Ó;
Respir Med; 2020; 170():106062. PubMed ID: 32843180
[TBL] [Abstract][Full Text] [Related]
7. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis.
McClenaghan E; Cosgriff R; Brownlee K; Ahern S; Burgel PR; Byrnes CA; Colombo C; Corvol H; Cheng SY; Daneau G; Elbert A; Faro A; Goss CH; Gulmans V; Gutierrez H; de Monestrol I; Jung A; Justus LN; Kashirskaya N; Marshall BC; McKone E; Middleton PG; Mondejar-Lopez P; Pastor-Vivero MD; Padoan R; Rizvi S; Ruseckaite R; Salvatore M; Stephenson AL; Filho LVRDS; Melo J; Zampoli M; Carr SB;
J Cyst Fibros; 2020 Nov; 19(6):868-871. PubMed ID: 33183965
[TBL] [Abstract][Full Text] [Related]
8. Impact of COVID-19 on mental health: Effects on screening, care delivery, and people with cystic fibrosis.
Smith BA; Georgiopoulos AM; Mueller A; Abbott J; Lomas P; Aliaj E; Quittner AL
J Cyst Fibros; 2021 Dec; 20 Suppl 3():31-38. PubMed ID: 34930540
[TBL] [Abstract][Full Text] [Related]
9. Changes in Care during the COVID-19 Pandemic for People with Cystic Fibrosis.
Sanders DB; Wu R; O'Neil T; Elbert A; Petren K; Jain R; Ren CL
Ann Am Thorac Soc; 2022 Oct; 19(10):1697-1703. PubMed ID: 35143374
[No Abstract] [Full Text] [Related]
10. COVID-19 pandemic restrictions continuously impact on physical activity in adults with cystic fibrosis.
Radtke T; Haile SR; Dressel H; Benden C
PLoS One; 2021; 16(9):e0257852. PubMed ID: 34555108
[TBL] [Abstract][Full Text] [Related]
11. Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis.
Alicandro G; Orena BS; Rosazza C; Cariani L; Russo M; Zatelli M; Badolato R; Gramegna A; Blasi F; Daccò V
Vaccine; 2023 Jun; 41(28):4114-4120. PubMed ID: 37263872
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation.
Lucca F; Bezzerri V; Danese E; Olioso D; Peserico D; Boni C; Cucchetto G; Montagnana M; Tridello G; Meneghelli I; Ros M; Lippi G; Cipolli M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674422
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of SARS-CoV-2 IgG in people with cystic fibrosis.
Mahan K; Kiel S; Freese R; Marka N; Dunitz J; Billings J
Heliyon; 2024 Mar; 10(6):e27567. PubMed ID: 38501003
[TBL] [Abstract][Full Text] [Related]
14. Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic.
Mathew HR; Choi MY; Parkins MD; Fritzler MJ
BMC Pulm Med; 2021 May; 21(1):173. PubMed ID: 34016096
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of SARS-CoV-2 infection in patients with cystic fibrosis: A multicenter retrospective research network study.
Hadi YB; Lakhani DA; Naqvi SF; Fatima NU; Sarwari AR
Respir Med; 2021 Nov; 188():106606. PubMed ID: 34520894
[TBL] [Abstract][Full Text] [Related]
16. Recommended shielding against COVID-19 impacts physical activity levels in adults with cystic fibrosis.
Radtke T; Haile SR; Dressel H; Benden C
J Cyst Fibros; 2020 Nov; 19(6):875-879. PubMed ID: 32878732
[TBL] [Abstract][Full Text] [Related]
17. The clinical impact of the Covid-19 pandemic first wave on patients with cystic fibrosis in New York.
Simonson JL; Esposito C; Frantzen T; Henthorne K; Espinal A; Romano S; Ramdeo R; Trentacoste J; Tsang D; LaVecchia G; Abdullah R; Berdella M; Bonitz L; Condos R; Constantinescu A; DeCelie-Germana JK; DiMango E; Draine M; Gimeli T; Giusti R; Guzman J; Hammouda S; Keating C; Kier C; Lennox AT; Liriano C; Messer Z; Plachta A; Sadeghi H; Schwind E; Stables-Carney T; Walker P; Wang J
J Cyst Fibros; 2022 May; 21(3):e176-e183. PubMed ID: 35256307
[TBL] [Abstract][Full Text] [Related]
18. Remote monitoring in telehealth care delivery across the U.S. cystic fibrosis care network.
Ong T; Van Citters AD; Dowd C; Fullmer J; List R; Pai SA; Ren CL; Scalia P; Solomon GM; Sawicki GS
J Cyst Fibros; 2021 Dec; 20 Suppl 3():57-63. PubMed ID: 34930544
[TBL] [Abstract][Full Text] [Related]
19. Patient and family experience of telehealth care delivery as part of the CF chronic care model early in the COVID-19 pandemic.
Solomon GM; Bailey J; Lawlor J; Scalia P; Sawicki GS; Dowd C; Sabadosa KA; Van Citters A
J Cyst Fibros; 2021 Dec; 20 Suppl 3():41-46. PubMed ID: 34930542
[TBL] [Abstract][Full Text] [Related]
20. Telehealth use in cystic fibrosis during COVID-19: Association with race, ethnicity, and socioeconomic factors.
Albon D; Van Citters AD; Ong T; Dieni O; Dowd C; Willis A; Sabadosa KA; Scalia P; Reno K; Oates GR; Schechter MS
J Cyst Fibros; 2021 Dec; 20 Suppl 3():49-54. PubMed ID: 34930543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
